Morgan Stanley’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.36M | Sell |
|
|||||
|
2025
Q1 | $4.68M | Buy |
|
|||||
|
2024
Q4 | $5.55M | Sell |
|
|||||
|
2024
Q3 | $14.5M | Sell |
|
|||||
|
2024
Q2 | $19.6M | Buy |
|
|||||
|
2024
Q1 | $27.7M | Sell |
|
|||||
|
2023
Q4 | $61M | Buy |
|
|||||
|
2023
Q3 | $1.09M | Buy |
|
|||||
|
2023
Q2 | $761K | Sell |
|
|||||
|
2023
Q1 | $263K | Buy |
|
|||||
|
2022
Q4 | $85.7K | Buy |
|
|||||
|
2022
Q3 | $79K | Sell |
|
|||||
|
2022
Q2 | $91K | Buy |
|
|||||
|
2022
Q1 | $113K | Sell |
|
|||||
|
2021
Q4 | $243K | Buy |
|
|||||
|
2021
Q3 | $64K | Sell |
|
|||||
|
2021
Q2 | $150K | Buy |
|
|||||
|
2021
Q1 | $31K | Buy |
|
|||||
|
2020
Q4 | $13K | Sell |
|
|||||
|
2020
Q3 | $80K | Sell |
|
|||||
|
2020
Q2 | $118K | Buy |
|
|||||
|
2020
Q1 | $143K | Sell |
|
|||||
|
2019
Q4 | $556K | Buy |
|
|||||
|
2019
Q3 | $531K | Buy |
|
|||||
|
2019
Q2 | $451K | Sell |
|
|||||
|
2019
Q1 | $578K | Buy |
|
|||||
|
2018
Q4 | $519K | Hold |
|
|||||
|
2018
Q3 | $979K | Sell |
|
|||||
|
2018
Q2 | $577K | Buy |
|
|||||
|
2018
Q1 | $335K | Hold |
|
|||||
|
2017
Q4 | $297K | Hold |
|
|||||
|
2017
Q3 | $329K | Hold |
|
|||||
|
2017
Q2 | $469K | Hold |
|
|||||
|
2017
Q1 | $471K | Hold |
|
|||||
|
2016
Q4 | $469K | Hold |
|
|||||
|
2016
Q3 | $826K | Buy |
|
|||||
|
2016
Q2 | $776K | Sell |
|
|||||
|
2016
Q1 | $737K | Buy |
|
|||||
|
2015
Q4 | $1.32M | Sell |
|
|||||
|
2015
Q3 | $1.01M | Sell |
|
|||||
|
2015
Q2 | $1.05M | Sell |
|
|||||
|
2015
Q1 | $1.28M | Buy |
|
|||||
|
2014
Q4 | $1.17M | Buy |
|
|||||
|
2014
Q3 | $1.24M | Buy |
|
|||||
|
2014
Q2 | $1.21M | Buy |
|
|||||
|
2014
Q1 | $1.13M | Sell |
|
|||||
|
2013
Q4 | $1.09M | Buy |
|
|||||
|
2013
Q3 | $1.13M | Sell |
|
|||||
|
2013
Q2 | $1.06M | Buy |
|